Marker Therapeutics, Inc. (MRKR)
1.34
+0.08
(+6.35%)
USD |
NASDAQ |
Mar 25, 16:00
1.33
-0.01
(-0.75%)
Pre-Market: 08:39
Marker Therapeutics Free Cash Flow : -12.01M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viridian Therapeutics, Inc. | -277.36M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Kiniksa Pharmaceuticals International Plc | 136.42M |
| electroCore, Inc. | -8.253M |
| Agenus, Inc. | -77.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.900M |
| Free Cash Flow Per Share (Quarterly) | -0.114 |
| Free Cash Flow to Equity (Quarterly) | -1.900M |
| Free Cash Flow to Firm (Quarterly) | -1.900M |
| Free Cash Flow Yield | -61.31% |